Live feed
Filing
SC 13D/A
SC 13D/A0001144204-17-001420·Neurogene Inc.
Schedule 13D ownership disclosure
AQUINOX PHARMACEUTICALS, INC
Security class unavailable · CUSIP: 03842B101
Event date: 2017-01-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 10,934,154
- Percent of class
- 46.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-17-001420
- Form type
- SC 13D/A
- Filer
- Neurogene Inc.
- CIK
- CIK 1404644
- Filed
- Jan 09, 2017
- Reporting period
- Jan 09, 2017
- Description
- Schedule 13D beneficial ownership